{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:21:49Z","timestamp":1761988909398,"version":"3.41.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pharep.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T12:19:31Z","timestamp":1445861971000},"page":"363-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats"],"prefix":"10.1007","volume":"68","author":[{"given":"Marek","family":"Toczek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Baranowska-Kuczko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Grz\u0119da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"P\u0119dzi\u0144ska-Betiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Weresa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Malinowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"7","key":"10.1016\/j.pharep.2015.10.004_bib0215","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1111\/j.1476-5381.2011.01747.x","article-title":"Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?","volume":"165","author":"Malinowska","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.pharep.2015.10.004_bib0220","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease \u2013 successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.pharep.2015.10.004_bib0225","first-page":"171","article-title":"A new face of endocannabinoids in pharmacotherapy. Part I: protective role of endocannabinoids in hypertension and myocardial infarction","volume":"65","author":"Zubrzycki","year":"2014","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2015.10.004_bib0230","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/HJH.0b013e328329bbd7","article-title":"Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension","volume":"27","author":"Li","year":"2009","journal-title":"J Hypertens"},{"issue":"12","key":"10.1016\/j.pharep.2015.10.004_bib0235","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/HJH.0b013e3283591595","article-title":"Circulating anandamide and blood pressure in patients with obstructive sleep apnea","volume":"30","author":"Engeli","year":"2012","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.pharep.2015.10.004_bib0240","first-page":"191","article-title":"Effects of tetrahydrocannabinol on arterial and intraocular hypertension","volume":"17","author":"Crawford","year":"1979","journal-title":"Int J Clin Pharmacol Biopharm"},{"issue":"5","key":"10.1016\/j.pharep.2015.10.004_bib0245","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.HYP.29.5.1204","article-title":"Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats","volume":"29","author":"Lake","year":"1997","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.pharep.2015.10.004_bib0250","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension","volume":"110","author":"B\u00e1tkai","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1476-5381.2008.00034.x","article-title":"Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats","volume":"156","author":"Ho","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"20\u201321","key":"10.1016\/j.pharep.2015.10.004_bib0260","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.lfs.2013.03.014","article-title":"Myocardial hypertrophy is associated with inflammation and activation of endocannabinoid system in patients with aortic valve stenosis","volume":"92","author":"Duerr","year":"2013","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.pharep.2015.10.004_bib0265","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/FJC.0000000000000134","article-title":"Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes","volume":"64","author":"Lu","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2015.10.004_bib0270","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1159\/000323997","article-title":"Role for cannabinoid receptors in human proximal tubular hypertrophy","volume":"26","author":"Jenkin","year":"2010","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"10.1016\/j.pharep.2015.10.004_bib0275","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.ki.5002540","article-title":"Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats","volume":"72","author":"Janiak","year":"2007","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.pharep.2015.10.004_bib0280","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/jpet.106.112904","article-title":"Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet","volume":"321","author":"Wang","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharep.2015.10.004_bib0285","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/1056-8719(92)90036-Z","article-title":"The pathogenesis of DOCA-salt hypertension","volume":"27","author":"Schenk","year":"1992","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2015.10.004_bib0290","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.33549\/physiolres.932363","article-title":"Age-dependent salt hypertension in Dahl rats: fifty years of research","volume":"61","author":"Zicha","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.pharep.2015.10.004_bib0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2015.03.022","article-title":"Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats","author":"Toczek","year":"2015","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Rev"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0305","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S0029665113003649","article-title":"Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications","volume":"73","author":"Pertwee","year":"2014","journal-title":"Proc Nutr Soc"},{"issue":"11","key":"10.1016\/j.pharep.2015.10.004_bib0310","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.chembiol.2010.08.013","article-title":"Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects","volume":"17","author":"Godlewski","year":"2010","journal-title":"Chem Biol"},{"issue":"8","key":"10.1016\/j.pharep.2015.10.004_bib0315","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ajh.2008.198","article-title":"A human fatty acid amide hydrolase (FAAH) functional gene variant is associated with lower blood pressure in young males","volume":"21","author":"Sarzani","year":"2008","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0320","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/syn.21609","article-title":"Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period","volume":"67","author":"Lee","year":"2013","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0330","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-009-1592-6","article-title":"Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats","volume":"206","author":"Ward","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.pharep.2015.10.004_bib0335","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/01.HYP.8.12.1096","article-title":"Experimental hypertension in young and adult animals","volume":"8","author":"Zicha","year":"1986","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0340","first-page":"89","article-title":"Haemodynamics and the participation of pressor systems in young and adult rats with age-dependent DOCA-salt hypertension","volume":"36","author":"Zicha","year":"1987","journal-title":"Physiol Bohemoslov"},{"issue":"3","key":"10.1016\/j.pharep.2015.10.004_bib0345","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1476-5381.2012.02028.x","article-title":"Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system","volume":"167","author":"Okine","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2015.10.004_bib0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1742-2094-9-79","article-title":"The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation","volume":"9","author":"Murphy","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.pharep.2015.10.004_bib0355","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.biopsych.2011.04.022","article-title":"Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses","volume":"70","author":"Busquets-Garcia","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharep.2015.10.004_bib0360","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.pharep.2015.10.004_bib0365","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pbb.2011.06.022","article-title":"Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice","volume":"99","author":"Kinsey","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"10.1016\/j.pharep.2015.10.004_bib0370","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/ndt\/gfm321","article-title":"High salt intake: a cause of blood pressure-independent left ventricular hypertrophy?","volume":"22","author":"Burnier","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.pharep.2015.10.004_bib0375","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/apha.12092","article-title":"Chronic antioxidant therapy lowers blood pressure in adult but not in young Dahl salt hypertensive rats: the role of sympathetic nervous system","volume":"208","author":"Van\u011b\u010dkov\u00e1","year":"2013","journal-title":"Acta Physiol (Oxf)"},{"issue":"2","key":"10.1016\/j.pharep.2015.10.004_bib0380","doi-asserted-by":"crossref","first-page":"H909","DOI":"10.1152\/ajpheart.00373.2007","article-title":"Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase","volume":"293","author":"B\u00e1tkai","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.pharep.2015.10.004_bib0385","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/FJC.0000000000000216","article-title":"Alterations in the medullary endocannabinoid system contribute to age-related impairment of baroreflex sensitivity","volume":"65","author":"Schaich","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2015.10.004_bib0390","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","article-title":"Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells","volume":"10","author":"Idris","year":"2009","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.pharep.2015.10.004_bib0395","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.114.03633","article-title":"Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis","volume":"64","author":"Pulgar","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0400","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1748-1716.2011.02395.x","article-title":"Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats","volume":"205","author":"Zicha","year":"2012","journal-title":"Acta Physiol (Oxf)"},{"issue":"8.","key":"10.1016\/j.pharep.2015.10.004_bib0405","article-title":"Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats","volume":"2","author":"Schaich","year":"2014","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.004_bib0410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2010.11.002","article-title":"Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"10.1016\/j.pharep.2015.10.004_bib0415","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: mediating protection and recovery from stress","volume":"34","author":"Gunduz-Cinar","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.pharep.2015.10.004_bib0420","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:18Z","timestamp":1752611778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.10.004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1734114015003412"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.10.004","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}